Back to search

Article

Omalizumab for the Treatment of Allergic Rhinitis: A Systematic Review and Meta-Analysis

2024-01-30

Abstract excerpt

<h4>Background: </h4> Allergic rhinitis (AR), an IgE-mediated inflammatory disease, significantly impacts the quality of life of a considerable proportion of the general population. Omalizumab, a humanized monoclonal antibody against IgE, has been evaluated for both seasonal and perennial AR. We aimed to assess the efficacy and safety of omalizumab in randomized controlled trials (RCTs) in inadequately controlled...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
0eac636d-b992-570d-9d1c-6ea4fe7ebf45
DOI
10.22541/au.170665836.66308695/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Omalizumab for the Treatment of Allergic Rhinitis: A Systematic Review and Meta-AnalysisDOI 10.22541/au.170665836.66308695/v1
Select a neighboring publication to make it the new centre.